parvovirus B19
Jump to navigation
Jump to search
Introduction
parvovirus B19, human
Pathology
- arthritis
- hypoplastic anemia & pancytopenia may occur in adults
- infects erythrocyte precursors (giant, abnormal proerythroblasts)
- transient aplasia, reversing spontaneously in a week or two
- generally becomes apparent only in individuals with underlying chronic hemolytic anemia (sickle cell anemia), dependent upon increased erythrocyte production
- erythema infectiousum in children
- hydrops fetalis
- generally does not harm fetus
- can cause fetal anemia, cardiac failure, hydrops fetalis
- risk greatest 9-20 weeks of gestation & 2-4 weeks after maternal infection[10]
- can cause fetal anemia, cardiac failure, hydrops fetalis
Clinical manifestations
- nonspecific, flulike symptoms may precede rash
- facial rash
- erythematous malar rash (slapped-cheek rash, erythema infectiousum)
- facial rash often followed by a generalized reticular or maculopapular rash
- faint maculopapular rash on chest & arms
- case with no facial rash[10]
- systemic symptoms have usually resolved with appearance of generalized maculpapular rash[6][8][9]
- rheumatoid arthritis-like syndrome in adults
- acute symmetric inflammatory polyarthritis
- rash may be absent in adults
- hands, wrists & knees most commonly affected
- small joints of the hands most often affected
- MCP joints affected
- small joints of the hands most often affected
- median duration is 10 days; however a few cases may last for years
Laboratory
- parvovirus B19 IgM
- test in pregnant woman 2-4 weeks after maternal infection[10]
- PCR/RT-PCR for parvovirus B19
- see ARUP consult[3]
Complications
- pure red cell aplasia
- direct antiglobulin test (DAT) would rule out pure red cell aplasia (even in patients with CLL known for positive DAT in some patients)[7]
Differential diagnosis
- disseminated gonorrhea
- no flu-like syndrome of headache, fever, myalgia preceding rash
- symptoms of fever, chills & malaise may precede migratory arthritis & rash by a week or two
- asymmetric arthritis, oligoarthritis or monoarthritis favors gonorrhea
- a positive history of sexual activity increases likelihood of gonorrhea
- purulent conjunctivitis not a feature of parvovirus B19
- migratory arthritis not a feature of parvovirus B19
- no flu-like syndrome of headache, fever, myalgia preceding rash
Management
- NSAID for symptomatic treatment
- intravenous immunoglobulin
More general terms
References
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 455
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11,16,17,18. American College of Physicians, Philadelphia 1998,2012,2015,2018,
- ↑ 3.0 3.1 ARUP Consult: Parvovirus B19 The Physician's Guide to Laboratory Test Selection & Interpretation https://www.arupconsult.com/content/parvovirus-b19
- ↑ Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007 Feb 1;75(3):373-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17304869
- ↑ Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004 Feb 5;350(6):586-97. PMID: https://www.ncbi.nlm.nih.gov/pubmed/14762186
- ↑ 6.0 6.1 NEJM Knowledge+ May 12, 2015
- ↑ 7.0 7.1 Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
- ↑ 8.0 8.1 Page C, Francois C, Goeb V, Duverlie G. Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses. J Clin Virol. 2015 Nov;72:69-74. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26433772 Review.
- ↑ 9.0 9.1 Soderlund-Venermo M Emerging Human Parvoviruses: The Rocky Road to Fame. Annu Rev Virol. 2019 Sep 29;6(1):71-91. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31283445
- ↑ 10.0 10.1 10.2 10.3 NEJM Knowledge+